World Journal of Oncology, ISSN 1920-4531 print, 1920-454X online, Open Access
Article copyright, the authors; Journal compilation copyright, World J Oncol and Elmer Press Inc
Journal website http://www.wjon.org

Case Report

Volume 5, Number 2, April 2014, pages 68-71


Concurrent Acute Monoblastic Leukemia and Multiple Myeloma in a 66-Year-Old Chemotherapy-Naive Woman

Table

Table 1. Review of previous reported cases of concurrent AML and MM
 
AuthorAgeSexTypeParaproteinKaryotypeTreatmentSurvival
*Patient had pancytopenia for 3 years prior to the diagnosis. †Patient had pancytopenia for 5 years prior to the diagnosis. **Cases described in Rosner and Grunwald [17]. K: kappa light chain; λ: lambda light chain; F: female; M: male; NA: not available.
Kim [3]51MMyelo blasticΚComplexBortezomib; ara-C and idarubicin; ara-C and mitoxantrone, allo-SCTAlive at 421 days
Shukla [4]58FMyelo blasticIgG/λNAAnthracycline/ara-C1 month
Attili [5]57MMyelo blasticIgG/K46, XY/t(8;21)NASepsis on day 7
Luca [6]77MMonocyticIgG/λMonosomy 13, structural changes of Chr 1, 20q-NAOne month
Raz [7]68MMonoblasticIgG/K“No bizarre chromosomal changes”Cyclophosphamide followed 2 months later by melphalan followed by vincristine, melphalan, cyclophoside, prednisone2.5 years
Cleary [8]64MMyelomonocyticIgA/K46 XYCytarabine and daunorubicin4 months
Tursz [9]77*MMyeloblasticIgANANANA
74†MMyeloblasticIgG//λNAMercaptopurineFew months
Rosner [10]79MMyelomonocyticNANACyclophosphamide 150 mg/day and testosterone for 6 weeks, which was stopped then after. Methotrexate and prednisone once AML was diagnosed 5 months laterDied shortly after the diagnosis of AML
Taddeini [11]**73MNAIgG//λNACombination chemotherapyAbout 14 weeks
Parker [12]**79MNAIgGNormalCytarabine and daunorubicin; then after, 5 days of prednisone and melphalan since plasma cell increased in repeat bone marrow examAbout 12 weeks
Kastanas [13]**70MNAIgGNANANA
Annino [14]**74MMyelomonocyticIgG/KHypodiploidy and marker chromosomeNANA
Vallantin [15]**66MMyeloblasticIgG/λNANANA
Parapia [16]**79MIgG/λNormalCytarabine, daunorubicin and 6-thioguanineAbout 6 weeks